Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho to Set Examples in Reform
July 22, 2002
- GL for Treatment of Esophageal Cancer Prepared
July 22, 2002
- REGULATORY NEWS IN BRIEF
July 22, 2002
- Shortage of Pharmacists Unlikely: Korosho Survey
July 22, 2002
- Aiming to Become Agile, Nimble Innovative Drug Firm: Mr Kannan of Allergan
July 22, 2002
- MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
July 22, 2002
- Kyowa Hakko Pharma Business to Focus on Cancer, Allergy
July 22, 2002
- 11 of 15 Major Firms Introduce Researchers Rewarding Programs: Survey
July 22, 2002
- Nippon Kayaku Licensed Paclitaxel DDS from NanoCarrier
July 22, 2002
- Korosho Panel Recommends GLs for Infertility Therapy
July 22, 2002
- Fujisawa Licenses Cefzon to Xian-Janssen in China
July 22, 2002
- GL to Include MNZ in Secondary H. pylori Eradication Therapy
July 22, 2002
- Wholesaler-Maker Relationship Undergoing Drastic Changes: Mr Akiyama of Suzuken
July 22, 2002
- Olympus Codevelops New DNA Microarray System with PamGene
July 22, 2002
- Kuraya Sanseido Acquires ATOL's Business in Tokyo, Kanagawa
July 22, 2002
- Sankyo Pharma to Market Cygnus' GlucoWatch
July 22, 2002
- MOSS Institute to Be Listed on August 8
July 22, 2002
- Shionogi-GSK Announces 1st Clinical Trial Results for New Anti-HIV Drug
July 22, 2002
- Number of Wholesalers to Decrease to 3 to 40 by 2011: YRI Report
July 22, 2002
- First Study on Palliative Medicine in Japan Completed
July 22, 2002
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…